170 related articles for article (PubMed ID: 2122546)
1. Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Carlucci M; Valesini G; Violi F
Thromb Res; 1990 Aug; 59(3):609-17. PubMed ID: 2122546
[TBL] [Abstract][Full Text] [Related]
2. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
[TBL] [Abstract][Full Text] [Related]
3. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
4. Antibody to cardiolipin, lupus anticoagulant, and fetal death.
Lockshin MD; Qamar T; Druzin ML; Goei S
J Rheumatol; 1987 Apr; 14(2):259-62. PubMed ID: 3110418
[TBL] [Abstract][Full Text] [Related]
5. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
[TBL] [Abstract][Full Text] [Related]
6. Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodies.
Vogel JJ; Reber G; de Moerloose P
Thromb Res; 1991 Jun; 62(5):545-56. PubMed ID: 1910214
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies.
Valesini G; Violi F; Ferro D; Quintarelli C; Falco M; Tincani A; Balestrieri G; Balsano F
Clin Exp Rheumatol; 1989; 7(6):615-8. PubMed ID: 2515018
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of anticardiolipin antibodies and its significance in systemic lupus erythematosus].
Bao CD; Chen SL; Jiang SJ
Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):74-7, 125. PubMed ID: 2500315
[TBL] [Abstract][Full Text] [Related]
12. [Importance of antiphosphatidylserine antibodies in patients with lupus anticoagulant. Analysis of 30 cases].
Zuazu-Jausoro I; Oliver A; Monserrat I; Borrell M; Garí M; Pich I; Grau E; Fontcuberta J
Med Clin (Barc); 1990 Jul; 95(6):210-3. PubMed ID: 2123507
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of lupus anticoagulant in women with spontaneous abortion in Zaria.
Ibrahim IN; Mamman AI; Adaji SE; Hassan A; Babadoko AA
Niger J Clin Pract; 2017 Sep; 20(9):1145-1149. PubMed ID: 29072238
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Sukenik S; el-Roeiy A; Shoenfeld Y
Acta Haematol; 1986; 76(2-3):86-9. PubMed ID: 3101368
[TBL] [Abstract][Full Text] [Related]
15. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
Zhou DC; Dong Y; Pan JQ
Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
[TBL] [Abstract][Full Text] [Related]
17. Binding specificity of lupus anticoagulants and anticardiolipin antibodies.
McNeil HP; Chesterman CN; Krilis SA
Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207
[TBL] [Abstract][Full Text] [Related]
18. Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis.
Amer L; Kisiel W; Searles RP; Williams RC
Thromb Res; 1990 Jan; 57(2):247-58. PubMed ID: 2107591
[TBL] [Abstract][Full Text] [Related]
19. [A study on evaluation of circulating anticoagulant in borderline cases].
Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
Love PE; Santoro SA
Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
